17 report(s) found.
The bar graph to illustrate quantity money, that severel pharmaceutical firms spent on research in 2012, 2018 and 2022. To begin with, that Pharm company was leader among of all firms in question in 2012 and quantity spent money on research was about 9$bn, Fleming had slightly less money on researh in this year. And […]
The bar chart illustrated the expenditure of five big pharmaceutical manufacturers spend on research in 2012 and 2018 in addition estimate amount of year 2022. Overall, it is clear that nova pharmaceutical manufacturers have the highest rate of spending in year 2022 however pharm manufacturers had the least spending. In contrast ,novas pharmaceutical manufacturers experience […]
The bar chart shows the amount of investments into pharmaceutical research done by five leading companies from 2012 to 2018 and predictions for 2022. All companies show an upward trend in investments, with the most amount of money spent by Novas in 2018. Moreover, it has been estimated that this company will continue to be […]
The bar chart illustrates the proportion of billions of dollars spent by 5 large pharmaceutical organisations on research in 2012 and 2018 and the forecast for 2022. Overall, all companies showed the significant rise of spending over the periods: Pharm and Novas, which can show the greatest figure in 2022 too, were in the lead […]
The bar graph illustrates the financial investments allocated for research by five prominent pharmaceutical companies in the years 2012, 2018, and projected for 2022. Overall, it is evident that there has been a general upward trajectory in research spending across all companies over the specified years, with Novas consistently leading the expenditure. In 2012, Novas […]
The data displays the amount of money such pharmaceutical companies as Novas, Fleming, Biopharm, Avicenna and Pharm spent on subject study from 2012 to 2018. Also graph shows forecast of expenses in 2022. Overall, all companies showed an upward trend throughout the period with significant rise in their spendings. Each company started below 10 billion […]
The bar chart provides information about the amount of money, expressed in Sbn, that five large companies invest in medical study from 2012 to 2018 with a prediction till 2022. Overall, it is clear that there is an upward trend in all companies with according to forecast Novas spending the most money on research. Pharm […]
The bar chart provides two sets of data on how much money five pharmaceutical companies (Novas, Fleming, Biopharm, Avicenna and Pharm) invested in research in 2012, 2018 and 2022. In general, it is evident that in 2012 Pharm made the biggest contribution in research whereas Novas, Avicenna and Biopharm spent the least. However, in 2018 […]
The bar chart provides two sets of data on the amount of money five pharmaceutical companies (Novas, Fleming, Biopharm, Avicenna and Pharm) invested in research in 2012, 2018 and 2022. Overall, it is clear that the spending rose significantly among all five companies between 2012 and 2022, while the leading company judging by the amount […]
The given column graph illustrates the amounts of investing money to researches of five large pharmaceutical companies: Novas, Fleming, Biopharm, Avicenna and Pharm in 2012, 2018 and 2022. It is clear from the graph that all the companies had the trend for the increasing their investment. The ladder in increasing investment is “Novas” spending more […]
The bar chart demostrates the amount of money which five big pharmaceutical companies spent since 2012 till 2022. The data is measured in billion dollars. Overall, the expenses of all pharmaceutical companies were increasing during the time period. Every company has the same trend of rising but different quantitive values. On the on hand, Novas […]
The bar chart illustrates the budget devoted to research among five large medicine producing organizations between 2012 and 2018 and predicts the sum for 2022. Overall, the displayed data shows an increasing amount of money spent on research work by all companies. Predicted finance for research in 2022 generally exceeds the 2018 budget twice. In […]
the bar chart shows the amoun of money spent on survey by five big companies in the pharmaceutic field. Every company has increased their spents, Novas are became the biggest research spender along with Fleming, and Pharm, despite being the biggest one in the first peiod, is predicted to become the least spending on research […]
The bar graph illustrates the financial investments made by five major pharmaceutical corporations in research activities over a ten year period from 2012 to 2022. Overall, it is clear that the amount of money spent on research by all companies grew over the period in question. However, while the expenditure of Novas brand rose considerably, […]
The bar chart shows the amount of money different pharmaceutical companies allocated for researches in 2012, 2018 and 2022. Overall, all the presented companies have a continual growth. Pharm has a steady increase through the years. Even though their research was the most funded in 2012, the situation has completely changed by 2022 and its […]
The bar chart shows the amount of money different pharmaceutical companies allocated for researches in 2012, 2018 and 2022. Overall, all the presented companies have a continual growth. Pharm has a steady increase through the years. Even though their research was the most funded in 2012, the situation has completely changed by 2022 and its […]
The bar chart illustrates the amount of money five major(large) drug companies spent on research in 2012, 2018 and 2022. We can see from the data that, in general, there was a growing tendency among the pharmaceutical corporations to spend more money on research over the period given. Overall, Fleming, Biopharm and Avicenna witnessed a […]